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Cells keep their energy balance and avoid oxidative
stress by regulating mitochondrial movement, distri-
bution, and clearance. We report here that two Par-
kinson’s disease proteins, the Ser/Thr kinase PINK1
and ubiquitin ligase Parkin, participate in this regula-
tion by arresting mitochondrial movement. PINK1
phosphorylates Miro, a component of the primary
motor/adaptor complex that anchors kinesin to the
mitochondrial surface. The phosphorylation of Miro
activates proteasomal degradation of Miro in a Par-
kin-dependent manner. Removal of Miro from the
mitochondrion also detaches kinesin from its sur-
face. By preventing mitochondrial movement, the
PINK1/Parkin pathway may quarantine damaged
mitochondria prior to their clearance. PINK1 has
been shown to act upstream of Parkin, but the mech-
anism corresponding to this relationship has not
been known. We propose that PINK1 phosphoryla-
tion of substrates triggers the subsequent action of
Parkin and the proteasome.
INTRODUCTION
Parkinson’s disease (PD) is one of the most common neurode-
generative disorders. The causes of neuronal death in PD remain
elusive, but mitochondrial malfunction is likely to be an important
component (Whitworth and Pallanck, 2009; Youle and Narendra,
2011). Two hereditary forms of early onset recessive PD arise
from mutations in PINK1, a Ser/Thr kinase, and Parkin, an E3
ubiquitin ligase (Kitada et al., 1998; Valente et al., 2004). These
genes affect mitochondrial function and morphology (Clark
et al., 2006; Exner et al., 2007; Park et al., 2006; Poole et al.,2008) and participate in a pathway for mitochondrial quality
control (Geisler et al., 2010; Narendra et al., 2008, 2010; Whit-
worth and Pallanck, 2009; Youle and Narendra, 2011).
Genetic studies in Drosophila established that PINK1 is
upstream of Parkin (Clark et al., 2006; Exner et al., 2007; Park
et al., 2006; Poole et al., 2008). PINK1 resides partially on the
outer mitochondrial membrane (OMM) with its C-terminal kinase
domain facing the cytosol (Zhou et al., 2008), though it is also
imported into mitochondria. The presence of PINK1 on the mito-
chondrial surface is enhanced by mitochondrial damage and
depolarization, which prevent mitochondrial import of PINK1
and its PARL-dependent cleavage (Deas et al., 2011; Jin et al.,
2010). No substrates of PINK1 on the mitochondrial surface
have presently been identified, but by an unknown mechanism,
PINK1 recruits Parkin to depolarized mitochondria. Activation
of the PINK1/Parkin pathway is required to remove the damaged
mitochondria (Geisler et al., 2010; Narendra et al., 2008, 2010).
Consequently, neurons lacking PINK1 or Parkinmay be impaired
in mitochondrial clearance and, therefore, in response to other
stresses, may be prone to degeneration (Gandhi et al., 2009;
Surmeier et al., 2010). It is unknown how PINK1 and Parkin
promote the clearance of the damaged mitochondria nor how
PINK1 recruits Parkin to mitochondria. Little is known about
the substrates of these enzymes, although recent data indicate
that mitofusin is a Parkin substrate (Poole et al., 2010; Karbowski
and Youle, 2011; Ziviani et al., 2010). Parkin causes degradation
of mitofusin (Clark et al., 2006; Exner et al., 2007; Park et al.,
2006; Poole et al., 2008) and the zinc finger protein PARIS/
ZNF746 (Shin et al., 2011). Additionally, several mitochondrial
proteins are downregulated upon Parkin expression in HeLa
cells and may therefore also be substrates of Parkin (Chan
et al., 2011). Thus, the Parkin pathway may regulate multiple
aspects of mitochondrial biology.
Recently, PINK1 immunoprecipitates were found to include
components of the motor/adaptor complex mediating axonal
transport of mitochondria (Weihofen et al., 2009). This complexCell 147, 893–906, November 11, 2011 ª2011 Elsevier Inc. 893
contains kinesin-1 heavy chain (KHC) and two essential adaptor
proteins, Miro and milton (Glater et al., 2006; Stowers et al.,
2002). Miro (also called RhoT) resides in the OMM (Fransson
et al., 2006) and by binding both Miro and KHC, milton (also
called OIP98/106 and TRAK1/2) recruits KHC to the mitochon-
drial surface.
The Miro/Milton/KHC complex is conserved from flies to
mammals (Brickley et al., 2005; Fransson et al., 2006; Glater
et al., 2006; Stowers et al., 2002) and is also the means by
which mitochondrial movement is regulated by cytoplasmic
Ca2+ (Macaskill et al., 2009; Saotome et al., 2008; Wang and
Schwarz, 2009a).
The association of PINK1 with this motor/adaptor complex
suggested that PINK1 might also be a regulator of mitochondrial
motility. We show that both PINK1 and Parkin halt mitochondrial
movement; PINK1 phosphorylates Miro and thereby initiates the
rapid degradation of Miro through a Parkin- and proteasome-
dependent pathway. The resulting release of kinesin from mito-
chondria may be an initial quarantining step prior to mitophagy
or a mechanism to spatially restrict their deleterious effects.
RESULTS
Overexpression of PINK1 or Parkin in Rat Hippocampal
Axons Decreases Mitochondrial Movement
We examined the effects of PINK1 on axonal transport of
mitochondria by live imaging in cultured rat hippocampal
neurons. We coexpressed mito-dsRed to label mitochondria,
synaptophysin-YFP (SYP-YFP) to label axons (Wang and
Schwarz, 2009a, 2009b), and PINK1-Flag (Weihofen et al.,
2009). By retrospective staining, 96.7% ± 2.27% of neurons
that were mito-dsRed and SYP-YFP positive were also PINK1-
Flag positive (Figure S1 available online). We determined the
percent of time that mitochondria spent in motion, their average
velocity, frequency of stopping and reversing direction, density,
and length (Table S1A). Percent of time in motion was selected
as the primary parameter for quantifying motility, rather than
percent of mitochondria that move, because the former distin-
guishes mitochondria that move for only a fraction of the obser-
vation period from those that move continuously. Expression of
PINK1 significantly inhibited mitochondrial movement in both
directions and, as expected from previous studies, shortened
their length (Deng et al., 2008; Poole et al., 2008) but did not
significantly alter their average velocities (Figures 1A, 1B, and
1F; Movies S1 and S2; and Table S1A). Expression of a kinase-
dead mutant (PINK1KD) did not arrest mitochondria, but expres-
sion of a mutant lacking the mitochondrial targeting sequence
(PINK1DMTS) did (Figures 1A, 1D, and 1F and Table S1A). The
targeting sequence has previously been shown to be dispens-
able for PINK1 binding to mitochondria via the milton/Miro
complex (Weihofen et al., 2009).
To examine the effects of Parkin, we coexpressedmito-dsRed
and YFP-Parkin (Narendra et al., 2008) and selected axons by
morphological criteria (Wang and Schwarz, 2009a) in YFP-posi-
tive cells. Expression of Parkin also significantly decreased the
amount of mitochondrial movement, but not velocity, in both
directions (Figures 1E and 1F, Movie S3, and Table S1A). The
inhibition was specific to mitochondria because movement of894 Cell 147, 893–906, November 11, 2011 ª2011 Elsevier Inc.synaptic vesicles labeled with SYP-YFP was affected neither
by PINK1 nor Parkin expression (Table S1B). The density of
axonal mitochondria was also significantly decreased by
PINK1 or Parkin expression (Table S1A), as might be expected
from either a diminished movement into the axon or increased
mitophagy.
PINK1 Functions Upstream of Parkin to Inhibit
Mitochondrial Motility
Because PINK1 requires Parkin for control of mitochondrial
morphology and clearance (Clark et al., 2006; Exner et al.,
2007; Narendra et al., 2010; Park et al., 2006), we asked whether
PINK1 also required Parkin for regulating mitochondrial motility.
We did not detect any differences in mitochondrial dynamics,
density, or length between cultured embryonic hippocampal
neurons from wild-type and Parkin/ mice (Goldberg et al.,
2003) in the absence of PINK1 overexpression (Table S2A).
However, whereas expression of PINK1 halted mitochondria in
wild-type axons, it failed to do so in the Parkin/ background
(Figures 2A–2D and 2I, Movies S4–S7, and Table S2A), even
when cells were transfected with 3-fold higher concentrations
of DNA than were needed to arrest mitochondria in wild-type
axons (Figure S2A). The efficacy of PINK1 expression in
Parkin/ neurons could be recovered if Parkin was coexpressed
(Figures 2H and 2I and Table S2A). Thus, PINK1-dependent
mitochondrial arrest requires Parkin. The arrest of mitochondrial
motility by Parkin in the absence of overexpressed PINK1 was
dependent on the level of Parkin expression. In wild-type
neurons, transfection with 0.5 mg Parkin DNA/well was sufficient
to arrest both directions, but in Parkin/ neurons, 1 mg DNA/well
was necessary (Figures 2E, 2F, 2I, and 2J). Presumably, the
higher level of transfection was necessary to compensate for
the lack of endogenous Parkin.
Physiologically, the PINK1/Parkin pathway can be activated
by mitochondrial depolarization (Geisler et al., 2010; Narendra
et al., 2008, 2010). We therefore asked whether depolarization
regulated motility via this pathway. When neurons were treated
with 80 mM Antimycin A, a complex III inhibitor, YFP-Parkin
accumulated on axonal mitochondria (Figure S2B), as has
been observed on depolarized nonneuronal mitochondria (Nar-
endra et al., 2008), and bidirectional motility decreased. This
effect was only partially dependent on Parkin: mitochondria
stopped after 15 min in wild-type, but not Parkin/ axons
(Figures 2K, S2C, and S2D and Table S2B); however, by
30 min, little movement was observed in either genotype (data
not shown). Antimycin A also decreased mitochondrial size in
both genotypes (Table S2B).
PINK1 Functions Upstream of Parkin to Inhibit
Mitochondrial Motility in Drosophila Larval Axons
We took advantage of the mutations and transgenes available
in Drosophila to examine axonal transport of mitochondria in
dissected third-instar larvae (Wang and Schwarz, 2009b). As in
mammalian neurons, overexpression of PINK1 or Parkin signifi-
cantly decreased bidirectional motility. Knockdown of PINK1
or Parkin by RNAi significantly increased anterograde mito-
chondrial motility, and PINK1 RNAi also increased retrograde
movement. The effect of Parkin-RNAi did not reach statistical
Figure 1. PINK1 or Parkin Overexpression Arrests Mitochondria in Rat Hippocampal Axons
(A–E) Mitochondrial movement in representative axons transfected with mito-dsRed. The first frame of each live-imaging series is shown above a kymograph
generated from themovie. The x axis of each representsmitochondrial position, and the y axis is time (moving from top to bottom). Vertical white lines correspond
to stationary mitochondria, and diagonal lines are moving mitochondria. To illustrate the interpretation of kymographs, the bottom panels extract only the moving
mitochondria, which are shown as red (anterograde) or blue (retrograde) diagonal lines. Axons were tranfected with mito-dsRed alone (A) or together with PINK1-
Flag (B), kinase-dead PINK1 (PINK1KD-Flag) (C), PINK1DMTS-Flag (D), or YFP-Parkin (E).
(F) From kymographs as in (A–E), the percentage of time each mitochondrion was in motion was determined and averaged. n = 81–136 mitochondria from eight
axons and four separate transfections per genotype.
*p < 0.05, **p < 0.01, and ***p < 0.001. Error bars represent mean ± SEM. Scale bars, 10 mm. See also Figure S1, Movies S1–S3, and Table S1.significance for the retrograde direction for reasons not presently
understood (Figures 3A–3E and 3H, Movies S8–S12, and
Table S3). PINK1 or Parkin overexpression also significantly
shortened mitochondria (Table S3). Expression of Parkin RNAi
together with PINK1 prevented PINK1-mediated arrest of
mitochondrial motility, but expression of PINK1 RNAi did not
interfere with the ability of Parkin expression to stop mitochon-
dria (Figures 3F–3H and Table S3). Thus PINK1-dependent
mitochondrial arrest required Parkin, but Parkin-dependent
mitochondrial arrest did not require normal levels of PINK1
expression. These findings indicate that PINK1 and Parkin func-
tion in a common pathway to inhibit mitochondrial motility with
Parkin acting downstream of PINK1 in bothDrosophila andmice.The PINK1/Parkin Pathway Induces Miro Degradation
and Releases Kinesin from Mitochondria
Because Parkin is an E3 ubiquitin ligase, we hypothesized that
mitochondrial arrest could involve the degradation of compo-
nents of the motor/adaptor complex. We expressed either
PINK1 or Parkin in HEK293T cells with 60% transfection effi-
ciency (Figure S3A). Levels of endogenous Miro and milton
were significantly decreased compared to control when either
wild-type Parkin or PINK1, but not PINK1KD, was overex-
pressed. Loss of Miro and milton could be prevented with the
proteasome inhibitor MG132 (Figures 4A and 4B). The decrease
in Miro and milton was not due to a uniform destruction of mito-
chondria because neither the OMM proteins TOM20 and VDACCell 147, 893–906, November 11, 2011 ª2011 Elsevier Inc. 895
Figure 2. PINK1-Dependent Mitochondrial Arrest Requires Parkin
Mouse hippocampal axons were transfected with mito-dsRed and analyzed within kymographs, as in Figure 1.
(A) A wild-type (Parkin+/+) axon.
(B) A Parkin/ axon in which mitochondrial movement appears normal.
(C and D) Expression of PINK1-Flag arrested mitochondria in a wild-type axon (C), but not in a Parkin/ axon (D).
(E and F) Transfection with 0.5 mg YFP-Parkin DNA per well arrested mitochondria in wild-type (E), but not Parkin/ (F) axons.
(G and H) Transfection with 0.5 mg YFP-Parkin DNA allowed PINK1 expression to arrest mitochondria in both wild-type (G) or Parkin/ (H) axons.
(I) From kymographs as in (A–H), the percent of time each mitochondrion was in motion was determined and averaged. n = 108–157 mitochondria from eight
axons and four separate transfections per genotype.
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Figure 3. PINK1 Functions Upstream of Parkin to Inhibit Mitochondrial Movement in Drosophila CCAP Axons
For each genotype, UAS-mito-GFP was expressed in a single axon within the segmental nerve by CCAP-GAL4. The first frame of the live-imaging series appears
above the kymograph.
(A) Mitochondrial movement in a control larva.
(B–G) PINK1 or hParkin decreased, and PINK1-RNAi or Parkin-RNAi increased mitochondrial movement when expressed in that axon. Expression of
hParkin together with PINK1-RNAi arrested mitochondria (F), but expression of PINK1 together with Parkin-RNAi did not (G).
(H) From kymographs as in (A)–(G), the percent of time each mitochondrion was in motion was determined, averaged, and compared with control. n = 66–162
mitochondria from eight axons and four animals per genotype.
n.s., not significant. Error bars represent mean ± SEM. Scale bars, 10 mm. See also Movies S8–S12 and Table S3.nor the matrix proteins ATP5b and HSP60 were decreased
(Figures 4A–4D). Expression of PINK1 and Parkin together signif-
icantly degraded both Miro and VDAC, and levels of TOM20,
HSP60, and ATP5b also tended to decrease; this broader loss
of mitochondrial proteins upon coexpression of PINK1 and
Parkin might represent an early stage of mitophagy (Figures 4C
and 4D). In contrast to the selective loss of Miro upon PINK1 or
Parkin expression, the explicit induction of mitophagy by a
24 hr incubation with CCCP (Geisler et al., 2010; Narendra(J) Mitochondrial motility as a function of the amount of transfected YFP-Parkin
four separate transfections per genotype.
(K) Movies were taken before and after 15 min incubation with 80 mM Antimyc
mitochondria from eight axons and eight separate transfections per genotype.
p values were calculated by comparing a given genotype to its control in (I), to 0
Error bars represent mean ± SEM. Scale bars, 10 mm. See also Figure S2, Movieet al., 2010) significantly degraded all of the mitochondrial
markers except HSP60 (Figures 4C and 4D). HSP60 induction
by mitochondrial stress may cause its levels to decline more
slowly (Chan et al., 2011). Expressed human Miro or Drosophila
Miro was also degraded upon expression of human PINK1 or
human Parkin (Figures S3B and S3C). The likely conservation
of the degradation pathway is consistent with the ability of
PINK1 and Parkin to arrest mitochondrial motility in both
mammalian and Drosophila neurons.DNA/well of a 24-well plate. n = 97–157 mitochondria from eight axons and
in A and analyzed by kymograph (see Figures S2C and S2D). n = 140–174
Before Antimycin A, Parkin+/+ and Parkin/ axons did not significantly differ.
mg Parkin DNA in (J), and by comparing before and after Antimycin A in (K).
s S4–S7, and Table S2.
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Figure 4. The PINK1/Parkin Pathway Causes Miro to be Degraded
(A and B) Endogenous Miro1 and h-milton1 were degraded by either PINK1 or Parkin expression in a proteasome-dependent manner. HEK293T cells were
transfected with PINK1-Flag, PINK1KD-Flag, or YFP-Parkin and grown in the presence or absence of MG132. Cell lysates were analyzed by immunoblot as
indicated. n = 3 transfections.
(C and D) PINK1 and Parkin selectively decrease Miro1 levels and not other mitochondrial proteins. Cells were transfected with PINK1-Flag, YFP-Parkin, or both
or treated with CCCP 20 mM for 24 hr to promote mitophagy. Lysates were analyzed by immunoblot as indicated. n = 3 transfections.
(A–D) Quantification was with a fluorescence scanner in the linear range. The intensity of each band was normalized to that of tubulin and expressed relative to
normalized levels in control cells.
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Expression of either PINK1 or Parkin in HEK293T cells signifi-
cantly lowered the levels of Miro, Milton, and KHC on mitochon-
dria. In the cytosol, levels of milton and KHC tended to increase,
though these changes were highly variable and did not reach
statistical significance (Figures 4E and 4F). The presence of
KHC on other organelles may have obscured detection of KHC
released from mitochondria. Miro is a requisite receptor for
Milton and KHC on the mitochondrial surface (Glater et al.,
2006). Therefore, if Miro is a direct target of proteasome-depen-
dent degradation, it would likely cause loss of the entire complex
from the mitochondrial surface and thereby explain mitochon-
drial arrest, although degradation of milton and KHC is also
possible. The proteasomal degradation of membrane proteins
such as Miro typically involves the intermediate step of removing
the protein from the membrane by proteins such as p97 prior to
its degradation, and p97 has been shown to be activated by the
PINK1/Parkin pathway (Karbowski and Youle, 2011). Loss of
mitochondrial motility might therefore be achieved when Miro
is removed from the membrane, even before its eventual
degradation.
Because PINK1 acts via Parkin in arresting mitochondria,
PINK1was predicted to require Parkin to promoteMiro degrada-
tion. This relationship was tested in HeLa cells because they lack
endogenous Parkin (Narendra et al., 2008). In HeLa cells, PINK1
overexpression did not significantly decrease cotransfected
Myc-Miro levels unless Parkin was also cotransfected. As seen
in HEK293T cells, Myc-Miro was selectively degraded when
both PINK1 and Parkin were expressed; levels of the cotrans-
fected mitochondrial marker (SIRT4) were unaffected (Figures
4G and 4H). Thus, Parkin is required for PINK1-induced loss of
Miro. Although expression of Parkin without coexpression of
PINK1 could also cause loss of Myc-Miro in HeLa cells, it
required a higher ratio of Parkin to Miro DNA in the transfection
(1:1) than that which was needed for HEK293T cells (1:2) (Figures
4G, S3D, and S3E). As was seen in Parkin/ neurons, higher
levels of Parkin transfection are likely required in HeLa cells
due to the lack of endogenous Parkin.
We also tested pathogenic point mutations found in human
Parkin (Berger et al., 2009) (Figures 4I and 4J). R42P disrupts
the ubiquitin-like domain, and R275W disrupts the RING1
domain, whereas W453X truncates the protein after the RING2
domain. The phenotypes associated with these alleles suggest
that they have attenuated functions. We found that expression
in HEK293T cells of either ParkinR275W or ParkinW453X failed
to decrease coexpressed Myc-Miro levels, but Parkin R42P did.
The latter allele has previously been shown to retain ligase activity
and an affinity for some, but not all, targets (Sriram et al., 2005).(E and F) PINK1 or Parkin expression in HEK293T cells decreased Miro1, h-m
For quantification, the intensity of each band was normalized to that of actin and
(G and H) PINK1-dependent degradation of Miro requires Parkin. HeLa cells we
together withMyc-Miro and SIRT4-Flag (a mitochondrial matrix marker), and cell ly
eachMiro1 and SIRT4 bandwas normalized to the intensity of ATP5b (a mitochond
n = 3 transfections.
(I and J) HEK293T cells transfected with Myc-Miro, together with wild-type (WT)
blotted with anti-Myc and detectedwith a linear range fluorescence scanner. The e
immunoblot and one-way Anova. p = 0.996; n = 4 transfections. (J) Quantificatio
intensity of ATP5b, and the control band was set as 1. n = 4 transfections.
Error bars represent mean ± SEM. See also Figure S3.Mitochondrial Depolarization Causes PINK1 and Parkin
to Associate with Miro and Causes Miro Degradation
To examine the mechanism that targets Miro for degradation, we
analyzed its interactionswith PINK1 andParkin. Both PINK1-Flag
and YFP-Parkin coprecipitated with Myc-Miro when expressed
(Figures 5A and 5B). Without exogenous expression, however,
very little interaction was observed for either endogenous PINK1
or endogenous Parkin in HEK293T cells with expressed Myc-
Miro. Their coprecipitationwasgreatly enhanced,however, if cells
were treatedwithCCCP (Figures5Cand5D). Thus, the interaction
of Miro with PINK1 and Parkin is triggered by mitochondrial
depolarization, consistentwithfindings thatPINK1 isnot imported
into damaged mitochondria (Jin et al., 2010) and accumulates,
along with Parkin, on the OMM (Narendra et al., 2008).
Parkin facilitated the arrest of mitochondrial movement upon
the loss of mitochondrial membrane potential (Figure 2K). To
ask whether this effect correlated with Miro degradation, we
applied 10 mMCCCP toHEK293T cells and examinedMiro levels
after 3 hr, a time prior to the onset of mitophagy, and normalized
levels of Miro immunoreactivity to ATP5b levels to control for any
general loss of mitochondrial proteins due to early mitophagy or
cell death. CCCP selectively reduced Miro levels to 25% of
control (Figures 5E and 5F). Thus, the degradation of Miro can
be evoked not only by overexpression of PINK1 or Parkin, but
also by mitochondrial depolarization.
Parallel experiments were conducted in HeLa cells transfected
with Myc-Miro, with or without cotransfection of Parkin at a 1:4
ratio of Parkin toMiro DNA. At this ratio, Miro expression persists
in HeLa cells (Figure S3D, S3E, and 5G), presumably because
Miro synthesis outpaces its degradation. Under these condi-
tions, but not in the absence of Parkin, 10 mM CCCP caused
the loss of Miro (Figures 5G and 5H). Thus, as with PINK1 over-
expression, CCCP-induced degradation of Miro cannot proceed
in HeLa cells unless Parkin expression is restored. Similarly, Miro
was degraded in neurons upon mitochondrial depolarization
with 80 mM Antimycin A. The decrease in Miro could be pre-
vented by MG132 (Figure S4). However, stabilization of Miro
levels by MG132 could not rescue the mitochondrial arrest
caused by Antimycin A (Figure 2K and data not shown). As dis-
cussed below, although mitochondrial depolarization causes
Miro degradation in both cell lines and neurons, the pathway
may not need to proceed all the way to proteasomal degradation
of Miro in order to stop mitochondria.
PINK1 Phosphorylates Miro
To determine whether Myc-Miro is a substrate of PINK1,
they were cotransfected in HEK293T cells. In an anti-Mycilton1, and KHC levels on mitochondria and increased cytosolic h-milton1.
expressed as a fraction of control levels. n = 3 transfections.
re transfected with PINK1-Flag, YFP-Parkin, or YFP-Parkin and PINK1-Flag,
sates were analyzed with antibodies to the tagged proteins. (H) The intensity of
rial matrix loading control) and expressed as a fraction of levels in control cells.
Parkin, ParkinR42P, ParkinR275W, or ParkinW453X were lysed and immuno-
xpression levels of the Parkin constructs were indistinguishable by quantitative
ns of Myc-Miro. The intensity of each Myc-Miro band was normalized to the
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Figure 5. PINK1 and Parkin Interact with Miro upon Mitochondrial Depolarization
The interactions of PINK1, Parkin, and Miro were examined in HEK293T cells transfected as indicated. For each assay, 50% of the precipitate and 10% of the
input were loaded.
(A and B) Immunoprecipitations using anti-Myc, anti-Flag, or anti-GFP. PINK1-Flag (A) and YFP-Parkin (B) were detected in Myc-Miro immunoprecipitates, and
Myc-Miro was detected in PINK1-Flag (A) or YFP-Parkin immunoprecipitates (B). MG132 was used to prevent Myc-Miro degradation.
(C and D) Immunoprecipitation of endogenous PINK1 (C) or Parkin (D). Myc-Miro coprecipitated efficiently with anti-PINK1 or anti-Parkin when cells were treated
with 40 mM CCCP for 10 min.
(E and F) HEK293T cells transfected with Myc-Miro were incubated with 10 mM CCCP in DMSO or DMSO alone for 3 hr prior to lysing the cells. Immunoblots
of lysates were probed with anti-Myc and detected with a fluorescence scanner for quantification (F) after normalization to the mitochondrial loading control
ATP5b and expressed as a fraction of the control value. n = 6 transfections.
(G) Cell lysates from HeLa cells transfected as indicated and exposed to CCCP or DMSO as in (E).
(H) Quantification of Myc-Miro levels, normalized to ATP5b and expressed as a fraction of the DMSO control. n = 4 transfections.
Error bars represent mean ± SEM. See also Figure S4.immunoprecipitate, antiphospho-Threonine detected a band
that comigrated with Miro (Figure 6A). To look for a direct phos-
phorylation, bacterially expressed Drosophila Miro 1–617, a
construct lacking the C-terminal transmembrane domain, was
incubated with Flag-tagged PINK1 or PINK1 KD. The in vitro-
phosphorylated Miro was then analyzed by immunoblotting. A
band of the size of Miro was detected with antiphospho-Serine
whenATPandPINK1, but not PINK1KD,were added (Figure 6B).
The immunoprecipitate was also analyzed by mass spectrom-
etry. Two phosphopeptides were identified corresponding to
amino acids 177–190 and 319–330 of DrosophilaMiro, although
the spectra could not determine which serine or threonine resi-
dues within the peptides were modified (Figures 6C and S5).
When either ATP or PINK1 was omitted from the reaction,900 Cell 147, 893–906, November 11, 2011 ª2011 Elsevier Inc.mass spectrometry did not detect the phosphorylated peptides,
although the peaks corresponding to unphosphorylated Miro
peptides were equivalent in the samples. In human Miro1 and
Miro2, three of the potentially phosphorylated serine and threo-
nine residues within the Drosophila phosphopeptides had clear
homologs: in Miro1, Ser156 (homologous to Ser182 in
Drosophila) and in Thr298, 299 (homologous to Ser324, 325 in
Drosophila; Figure 6C).
Ser156 of Human Miro Mediates the Effects
of PINK1 and Parkin Expression
Identification of phosphorylation sites allowed us to investigate
their significance in triggering Miro degradation. To identify the
necessary regions, we first split the coding region of human
Figure 6. PINK1 Phosphorylation of Miro Is Necessary for PINK1/Parkin-Dependent Miro Degradation
(A) Immunoprecipitated Myc-Miro was recognized by anti-phospho-Threonine only when PINK1-Flag was coexpressed in HEK293T cells. MG132 was present
to prevent Miro degradation.
(B) PINK1 or PINK1 KD was immunoprecipitated from HEK293T cell lysates and added to bacterially expressed His-tagged DrosophilaMiro for an in vitro kinase
assay and then probed with anti-phospho-Serine and anti-His.
(C) The two phosphopeptides identified in Drosophila Miro by mass spectrometry are aligned with hMiro1. Potential phosphorylation sites that are conserved
between the species are marked (*), and a box indicates a potential consensus for a PINK1 target.
(D) Miro1–169 can be degraded by PINK1 or Parkin overexpression. Lysates from cells transfected as indicated were immunoblotted with anti-Myc, anti-GFP,
anti-Flag, and anti-ATP5b. FL, full length. Succinyldehydrogenase (SDHA) is a mitochondrial matrix marker.
(E) Quantifications of MiroFL, Miro1–169, Miro170–396, and Miro396–618. The intensity of Myc-Miro bands was normalized to SDHA-Myc levels with the control
level set as 1. n = 3 transfections.
(F) After transfection with wild-type or mutated forms of Myc-Miro and YFP-Parkin, lysates were prepared and immunoprobed with anti-Myc, anti-ATP5b, and
anti-GFP.
(G) Quantifications of Myc-Miro immunoreactivity in (F). The intensity of each Myc-Miro band was normalized to the intensity of ATP5b, and the control band was
set as 1. n = 4 transfections.
(H) Cells transfected as indicated were blotted with anti-Myc, anti-ATP5b, and anti-Flag. All quantifications were with a fluorescence scanner in the linear range.
Error bars represent mean ± SEM. See also Figure S5.Miro into three pieces: Miro1–169, which contains the first
GTPase domain and the predicted first phosphorylation site at
Ser 156; Miro170–396, which contains the two EF hand motifs
and the second set of predicted phosphorylation sites; and
Miro396–618, which contains the second GTPase motif and
the transmembrane domain. We predicted that only regions of
the protein containing the necessary sequences for PINK1 and
Parkin action would be degraded upon their coexpression in
HEK293T cells. Levels of full-length Miro and Miro1–169 were
significantly lower in response to either PINK1 or Parkin expres-
sion, but levels of Miro170–396 and 396–618 were not dimin-ished (Figures 6D and 6E). We also individually mutated to
Alanine each of the three potential PINK1 phosphorylation sites
in human Miro (Ser156, Thr298, and Thr299) and determined
whether those alterations influenced the effect of Parkin expres-
sion. Only the Ser156Ala mutation (MiroS156A) significantly pre-
vented the loss of Miro in response to overexpressed Parkin
(Figures 6F and 6G). Ser156Ala also prevented the decrease in
Miro levels caused by overexpressed PINK1 (Figure 6H). Levels
of ATP5b were unaffected by PINK1 or Parkin expression, con-
firming that their effect was not due to mitophagy. Ser156
resides within the N-terminal portion of Miro, and its significanceCell 147, 893–906, November 11, 2011 ª2011 Elsevier Inc. 901
for PINK1- and Parkin-dependent degradation is thus con-
sistent with the sensitivity of this domain to degradation (Figures
6D and 6E).
The preceding experiments suggested a model in which
Ser156 of Miro is phosphorylated by PINK1, which triggers
Parkin-dependent degradation of Miro by the proteasome. This
model predicts that MiroS156A expression should permit axonal
transport of mitochondria to persist when PINK1 or Parkin is
expressed. We found, however, that overexpressed wild-type
Miro was sufficient to resist the arrest of mitochondria if trans-
fected at a 1:1 DNA ratio with PINK1 or Parkin (Table S4).
IncreasedMiro synthesis probably compensated for Miro degra-
dation. To examine the importance of the phosphorylation site,
therefore, we reduced expression of theMiro transgene to a level
at which wild-type Miro synthesis did not outpace its degrada-
tion: a 3:1 DNA transfection ratio of PINK1 or Parkin to Miro. At
this ratio, transfection of PINK1 or Parkin with wild-type Miro
stopped mitochondria, but movement persisted when MiroS156A
was used. Overexpression of Miro or MiroS156A alone at this level
did not affect mitochondrial motility (Figures 7A–7E and Table
S4), and protein levels of overexpressed Miro or MiroS156A on
mitochondria were indistinguishable (Figure S6). Ser156 there-
fore has a key role in PINK1- and Parkin-driven degradation of
Miro and mitochondrial arrest.
DISCUSSION
Although genetic and cell biological data have placed PINK1
upstream of Parkin in a pathway that regulates mitochondrial
morphology and degradation, the relationship of the two
enzymes has been obscure. One model proposes that Parkin
is a PINK1 substrate activated by phosphorylation, but others
have failed to find this phosphorylation (Vives-Bauza and Przed-
borski, 2011). Our findings indicate an alternative model: PINK1
and Parkin bind to the same target (Figures 5A–5D), and its
phosphorylation by PINK1 (Figure 6) allows Parkin, presumably
acting as an ubiquitin ligase, to designate that protein for removal
from the mitochondrial membrane and proteasomal degrada-
tion. Indeed, hMiro1 and hMiro2 recently appeared among a
list of proteins downregulated by Parkin overexpression and
CCCP (Chan et al., 2011). The ability of Parkin to bring about
Miro degradation is consistent with its ability to ubiquitinate mi-
tofusin and thereby to cause its degradation through the sequen-
tial action of p97/VPC and the proteasome (Karbowski and
Youle, 2011). Interestingly, Miro and mitofusin interact with one
another (Misko et al., 2010), and their shared interaction with
Parkin suggests coordinated regulation. We have identified
two Miro peptides phosphorylated by PINK1, and at least one
phosphorylation site, Serine 156, is important for the subsequent
action of Parkin and the proteasome (Figures 6 and 7). We have
not directly examined the function of p97/VPC, but it is likely also
to be required to remove Miro from the OMM so that Miro can be
accessed by the proteasome. This may be the stage of the
pathway at which milton and kinesin are released from the mito-
chondrial surface and mitochondria stop. Our genetic and
biochemical data indicate that arrest by PINK1 expression
occurs downstream of Parkin, but the inability of MG132 to
prevent this arrest suggests that the degradation of Miro occurs902 Cell 147, 893–906, November 11, 2011 ª2011 Elsevier Inc.after the complex has been removed from the surface and
motility has ceased.
Mitochondrial motility is especially critical to neurons in which
it may take days for a mitochondrion to move between the cell
body and a distant axonal or dendritic ending. The need for mito-
chondria to undergo turnover, as well as their redistribution to
balance changes in local energy demand, make mitochondrial
movement an important ongoing and regulated process. The
mitochondrion-specific adaptor proteins, Miro and milton, are
control points for this motility, as illustrated by the pathway
that we have examined (Figure 7F).
Arrest by removal via this pathway provides an interesting
contrast with the previously reported mechanism of Ca2+-
dependent arrest (Wang and Schwarz, 2009a). The latter is
accomplished by a conformational change within the complex:
when Ca2+ binds to the EF hands of Miro, the motor domain of
kinesin binds directly toMiro and is thereby prevented from inter-
acting with microtubules. Kinesin remains bound to the mito-
chondrion, and therefore the mechanism is easily reversible
once Ca2+ is removed. Although an alternative model was pro-
posed in which Ca2+ dissociated the motor/adaptor complex
(Macaskill et al., 2009), this has not been observed by others
(Wang and Schwarz, 2009a; Brickley et al., 2011). The Ser/Thr
kinase and ubiquitin ligase cascade that constitutes the PINK1/
Parkin pathway, however, brings about an irreversible change
via the degradation of Miro (Figures 4 and 7F).
This distinction likely reflects the different cellular purposes of
the pathways. Whereas Ca2+ likely triggers a transient local
response to a temporary need for additional mitochondria,
PINK1 and Parkin initiate an irreversible pathway for clearing
damaged mitochondria. Consistent with this, depolarization of
mitochondria with CCCP greatly increased the association of
PINK1 and Parkin with Miro (Figures 5C and 5D), and depolariza-
tion was sufficient to trigger the loss of Miro from HEK293T cells,
HeLa cells, and neurons, provided that Parkin was present
(Figures 5E–5H and S4).
Damaged mitochondria in cell lines selectively recruit Parkin
and are in turn targeted for mitophagy (Narendra et al., 2008).
In contrast to an earlier report (Van Laar et al., 2011), we find
that this recruitment also occurs in axons; when highly ex-
pressed, YFP-Parkin was observed on mitochondria without
depolarization (consistent with its ability to arrest mitochondrial
motility upon overexpression), but with lower expression levels,
it was recruited to mitochondria by treatment with Antimycin A
(Figure S2B). Parkin recruitment is initiated by the depolariza-
tion-induced stabilization of PINK1 on the mitochondrial surface
(Geisler et al., 2010; Jin et al., 2010; Narendra et al., 2010), and
PINK1 is also upstream of Parkin in regulating mitochondrial
morphology (Clark et al., 2006; Exner et al., 2007; Park et al.,
2006; Poole at al., 2008). This relationship also holds for mito-
chondrial motility. PINK1 arrested mitochondrial motility in
wild-type, but not Parkin/mice or Parkin RNAi flies. Mitochon-
drial depolarization with CCCP caused the degradation of Miro
in a Parkin-dependent manner. Similarly, PINK1 expression
brought about the degradation of Miro in Parkin-expressing
cells, but not in Parkin-lacking HeLa cells (Figures 2–5).
Why is Miro targeted as part of a mitophagy pathway? One
possibility is that the arrest of mitochondrial motility, like the
Figure 7. MiroS156A Prevents Mitochondrial Arrest by PINK1/Parkin Overexpression in Rat Hippocampal Axons
(A and B) Expression of PINK1-Flag (A) or YFP-Parkin (B) at a 3:1 ratio to wild-type Miro arrested mitochondria.
(C and D) Expression of PINK1-Flag (C) or YFP-Parkin (D) at a 3:1 ratio to MiroS156A did not arrest mitochondria.
(E) From kymographs as in (A)–(D), the percent of time each mitochondrion was in motion was determined and averaged. n = 85–153 mitochondria from eight
axons and four separate transfections per genotype.
(F) Schematic representation of the proposed mechanism of PINK1/Parkin-dependent mitochondrial arrest. Mitochondrial depolarization stabilizes PINK1 on the
surface of the mitochondrion, promotes its interaction with Miro, and causes PINK1 to phosphorylate Ser156 of Miro. Subsequent interaction of Parkin with Miro
and likely ubiquitination causes Miro to be removed from the membrane and degraded by the proteasome, releasing milton and kinesin from the organelle.
Error bars represent mean ± SEM. Scale bars, 10 mm. See also Figure S6 and Table S4.prevention of mitochondrial fusion by mitofusin degradation,
helps to quarantine a depolarized mitochondrion or mitochon-
drial fragment prior to its engulfment by an autophagosome.
Stationary mitochondria are less likely to undergo fusion with
other mitochondria (Twig et al., 2010), and by immobilizing
unhealthy mitochondria, damage from released reactive oxygen
species would be confined to a smaller region. The fate of depo-
larized axonal mitochondria is not known, and they may be
degraded primarily in the soma. The neuron may, however,needs first to sequester the damaged organelle locally within
an autophagosome. Subsequent autophagosomal transport to
the soma would be independent of milton and Miro, which are
selectively on mitochondria.
In previous genetic studies of PINK1 and Parkin, differences
were noted between mice and Drosophila. Drosophila loss-of-
function mutants had profound defects in mitochondrial
morphology (Deng et al., 2008; Poole et al., 2008; Yang et al.,
2006) that were only seen in knockout mice when neuronsCell 147, 893–906, November 11, 2011 ª2011 Elsevier Inc. 903
were additionally stressed (Exner et al., 2007; Gautier et al.,
2008; Palacino et al., 2004). We also observed differences
betweenDrosophila andmurinemodels. In both, PINK1 or Parkin
overexpression arrested mitochondria, and in both, Parkin was
required downstream of PINK1. However, inDrosophila neurons,
RNAi knockdown of PINK1 or Parkin increased mitochondrial
motility, whereas we observed no statistically significant differ-
ences of motility in murine Parkin/ neurons. These differences
may reflect a difference in how the species employ the pathway:
in mammals, it may be strictly reserved for the response to mito-
chondrial depolarization (Figure 2K), whereas in the fly, whose
short life span may make mitochondrial damage less critical, it
may contribute to the ongoing turnover of proteins that partici-
pate in mitochondrial dynamics.
The ability of Parkin overexpression to alter mitochondrial
motility in the presence of PINK1 RNAi (Figure 3) ormitochondrial
morphology in a PINK1 null background (Clark et al., 2006) indi-
cates that, although PINK1 can stimulate Parkin function, Parkin
can act independently as well. In the current study, we do not
know whether Parkin is effective because of residual PINK1 in
the RNAi-expressing cells, because other kinases can also
activate Miro as a Parkin substrate, or because elevated levels
of Parkin can lead to Miro degradation even in the absence of
phosphorylation. PINK1 is likely to enhance Parkin function but
probably is not required.
Our observation that two PD-associated genes encode regula-
tors of mitochondrial motility is consistent with other findings
linkingmisregulationofmitochondrial dynamics toneurodegener-
ation. Changes in mitochondrial distribution, transport, and
dynamics are implicated in Charcot-Marie-Tooth, Amyotrophic
Lateral Sclerosis, and Alzheimer’s and Huntington’s diseases
(Schon and Przedborski, 2011). These findings underscore the
importance of mitochondrial dynamics for supplying distal re-
gions with sufficient energy and Ca2+-buffering capacity, com-
pensating for changes in energy demand, refreshing older mito-
chondria through fusion with newly synthesized mitochondria
(Frederick and Shaw, 2007), and clearing damagedmitochondria
(Whitworth and Pallanck, 2009; Youle and Narendra, 2011).
Miro joins a growing list of reported Parkin substrates (Chan
et al., 2011; Geisler et al., 2010; Poole et al., 2010; Shin et al.,
2011; Karbowski and Youle, 2011; Ziviani et al., 2010). It is
presently unknown whether any single substrate is critical for
subsequent mitophagy or whether ubiquitination or proteasomal
degradation of multiple mitochondrial surface proteins is
needed. It will also be important to determine whether PINK1
serves as a priming kinase for each of the Parkin substrates
and whether substrate phosphorylation is sufficient to promote
the action of Parkin. The phosphorylation sites recognized by
PINK1 fall in two regions of Miro: (1) at the C-terminal end of
the first GTPase domain of Miro and (2) between the two EF
hands (Figure 6C). Some sequence similarity between these
sites suggests a partial consensus for the enzyme (S/T E L/M).
Interestingly, a similar sequence can be found in mitofusin, sug-
gesting that PINK1 may phosphorylate mitofusin and thereby
regulate its Parkin-dependent ubiquitination (Poole et al., 2010;
Karbowski and Youle, 2011; Ziviani et al., 2010).
Clarification of the relationship of PINK1 and Parkin supports
the view that PD is a mitochondrial disorder (Whitworth and904 Cell 147, 893–906, November 11, 2011 ª2011 Elsevier Inc.Pallanck, 2009; Youle and Narendra, 2011). In the etiology of
PD, the regulation of Miro levels may be significant. Either
through a specific sorting pathway or as a consequence of the
random reassortment of mitochondrial proteins that occur with
repeated fusion and fission, some organelles or fragments of
the organelle will arise in which the burden of dysfunctional
proteins is sufficient to compromise the membrane potential.
The resulting stabilization of PINK1 on the surface (Deas et al.,
2011; Jin et al., 2010) and targeting of Miro, mitofusin, and other
proteins for Parkin action and degradation will bring about the
sequestration and eventual engulfment of that dysfunctional
organelle. Sequestration and mitophagy thereby prevent further
cellular damage due to reactive oxygen species and enable
the cellular complement of mitochondria to be replenished by
healthier organelles. The greater the stresses on mitochondria,
the more acute the need for this clearance pathway. The height-
ened sensitivity of the dopaminergic neurons in the substantia
nigra to disruption of this ubiquitous pathway may therefore
reflect exceptional challenges for mitochondria in these cells.
Those stresses may include the susceptibility of dopamine to
oxidation and high rates of Ca2+ influx (Surmeier et al., 2010).
When this quality control mechanism is defective in patients
carrying mutations in either gene, damaged mitochondria will
retain Miro and mitofusin and therefore may move about in the
neuron and, through fusion reactions, reintroduce damaged
components to otherwise healthy organelles rather than
undergo mitophagy.EXPERIMENTAL PROCEDURES
Fly Stocks
The following fly stocks were used:CCAP-GAL4 (Park et al., 2003),UAS-mito-
GFP (Pilling et al., 2006), UAS-PINK1 (Clark et al., 2006), UAS-hParkin (Yang
et al., 2006), UAS-PINK1RNAi (Yang et al., 2006), and UAS-ParkinRNAi
(Venderova et al., 2009; VDRC ID 47636).Constructs
The following constructs were used: mito-dsRed (Clontech); Synaptophysin-
YFP (Wang and Schwarz, 2009a); PINK1-Flag, PINK1KD-Flag, and
PINK1DMTS-Flag (Weihofen et al., 2009); YFP-Parkin, mCherry-Parkin (Nar-
endra et al., 2008); pcDH-Parkin, pcDH-ParkinR275W, pcDH-ParkinR42P,
and pcDH-ParkinW453X (Berger et al., 2009); pA1T7-DMiro (Glater et al.,
2006); pRK5Myc-Miro1 (Fransson et al., 2006). pRK5Myc-Miro1(1–169),
pRK5Myc-Miro1(170–396), and pRK5Myc-Miro1(396–618) were generated
by PCR amplification from pRK5Myc-Miro1 with BamHI/EcoRI-engineered
primers and then ligated into BamHI/EcoRI-digested pRK5Myc-Miro1.
Residues 1–5 of Miro1 were thereby retained in all three constructs, but no
Ser or Thr are present in this region. pRK5Myc-Miro1S156A, pRK5Myc-
Miro1T298A, and pRK5Myc-Miro1T299A were generated by site-directed
mutagenesis (Stratagene). Transfections of multiple constructs were done
with 1:1 ratios unless otherwise stated.Cell Culture
Hippocampal cells were dissociated from day 18 (rat) or day 17 (mouse)
embryos, cultured 5–7 days, transfected with Lipofectamine 2000 (Invitrogen),
and imaged 2 days later. Parkin/mice lacking exon3 (Goldberg et al., 2003)
were generated by intercrosses of C57BL/6 and 129/Sv hybrid parkin+/mice.
Wild-type mice were used as controls (Goldberg et al., 2003). HEK293T cells
were transfected with calcium phosphate (Wang and Schwarz, 2009a).
When used, MG132 (Sigma) was applied at 5 mM for 12–20 hr before lysis of
the cells.
Live Image Acquisition and Quantification
For neuronal cultures, confocal images were captured every 2–8 s as previ-
ously described (Wang and Schwarz, 2009a). Dissected third-instar larvae
were imaged in a chamber on a glass slide and maintained in Schneider’s
medium with 5 mM EGTA at 22C for less than 1 hr (Wang and Schwarz,
2009b). Images were captured every 2 s, and kymographs were generated
for an interval of 100 s. Details of quantification are in Extended Experimental
Procedures and Wang and Schwarz, 2009a.
Immunoprecipitation and Western Blotting
HEK293T or HeLa cells lysis and immunoprecipitations were performed as in
Wang and Schwarz, 2009a. Lysates were incubated with mouse anti-Myc
(9E10, Santa Cruz Biotechnology), rabbit anti-GFP (Invitrogen), rabbit anti-
Flag (Sigma), rabbit anti-PINK1 (BC100-494, Novus), mouse anti-Parkin
(sc32282, Santa Cruz), mouse anti-His (Invitrogen), and protein A Sepharose
beads (GE Healthcare, Piscataway, NJ) for 3 hr at 4C. See Extended Exper-
imental Procedures for use of antibodies.
In Vitro PINK1 Kinase Assay
See Extended Experimental Procedures for more details. The His-DMiro1-617
coding sequence was PCR amplified from a full-length cDNA construct
(Drosophila Genomics Resource Center clone RE22983) and inserted into
a pET17b(+) vector (Novagen). The plasmid was expressed in E. coli
BL21(DE3)RP cells. PINK1-Flag was immunoprecipitated from HEK293T cells
and added to the expressed His-DMiro1-617, with ATP (Sigma) and phospha-
tase inhibitor cocktails I and II (Sigma) in CK1 buffer (NEB). The reaction was at
30C for 2 hr and analyzed by immunoblotting.
Mass Spectrometry Analysis
Coomassie-stained gel bands were excised and minced. Details of the
procedures can be found in Extended Experimental Procedures.
Statistical Analysis
Throughout the paper, the distribution of data points is expressed as mean ±
standard error of themean. TheMann-WhitneyU tests were used for statistical
analysis unless otherwise indicated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
6 figures, 4 tables, and 12 movies and can be found with this article online
at doi:10.1016/j.cell.2011.10.018.
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